Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;71(2):299-309.
doi: 10.1007/s00018-013-1432-z. Epub 2013 Aug 4.

Recruitment and retention: factors that affect pericyte migration

Affiliations
Review

Recruitment and retention: factors that affect pericyte migration

Kristina Y Aguilera et al. Cell Mol Life Sci. 2014 Jan.

Abstract

Pericytes are critical for vascular morphogenesis and contribute to several pathologies, including cancer development and progression. The mechanisms governing pericyte migration and differentiation are complex and have not been fully established. Current literature suggests that platelet-derived growth factor/platelet-derived growth factor receptor-β, sphingosine 1-phosphate/endothelial differentiation gene-1, angiopoietin-1/tyrosine kinase with immunoglobulin-like and EGF-like domains 2, angiopoietin-2/tyrosine kinase with immunoglobulin-like and EGF-like domains 2, transforming growth factor β/activin receptor-like kinase 1, transforming growth factor β/activin receptor-like kinase 5, Semaphorin-3A/Neuropilin, and matrix metalloproteinase activity regulate the recruitment of pericytes to nascent vessels. Interestingly, many of these pathways are directly affected by secreted protein acidic and rich in cysteine (SPARC). Here, we summarize the function of these factors in pericyte migration and discuss if and how SPARC might influence these activities and thus provide an additional layer of control for the recruitment of vascular support cells. Additionally, the consequences of targeted inhibition of pericytes in tumors and the current understanding of pericyte recruitment in pathological environments are discussed.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to disclose.

Figures

Fig. 1
Fig. 1
Factors involved in pericyte recruitment and retention during angiogenesis. Angiogenesis requires pericyte–endothelial cell (EC) dissociation, pericyte migration and proliferation. Pericyte mobilization is driven by several factors (PDGF, Ang1, ALK1, S1P, EGF, and Sema3A) and is negatively regulated by others (TGFβ, Ang2, ALK5). The mobilized pericyte is recruited to a nascent vessel through the activity of factors such as SPARC, MMP9, and Sema3A, which results in vessel stabilization
Fig. 2
Fig. 2
Modulation of pericyte recruitment at the pericyte-EC interface. Pericyte recruitment to vascular endothelial cells (ECs) is controlled by a complex interplay between multiple signaling pathways. The schematic illustrates some of the better understood signaling cascades that affect pericyte recruitment. PDGF and EGF are released by ECs and bind to PDGFR-β and EGFR (respectively) on pericytes, stimulating pericyte migration and proliferation. S1P binds to EDG-1 expressed by pericytes and ECs, promoting pericyte migration. The Ang1/Tie2 complex enhances pericyte–EC interaction and induces the expression and release of EGF. Ang2 released by ECs binds to Tie2 on ECs and promotes pericyte-EC dissociation. TGFβ binds to TGFβR2, leading to the activation of ALK1 or ALK5. ALK1 activation stimulates pericyte recruitment while ALK5 activation results in cellular quiescence. Sema3A is released by ECs and forms a complex with Nrp1 and Plexin. This promotes enhanced EC migration and vessel remodeling. MMP9 and SPARC drive ECM remodeling, which facilitates growth factor activation and stimulates pericyte recruitment. SPARC, produced by ECs and pericytes, limits the activation of TGFβ and interferes with the ligation of PDGFR and EFGR to their respective ligands

References

    1. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193–215. - PubMed
    1. Dulauroy S, et al. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med. 2012;18:1262–1270. - PubMed
    1. Benjamin LE, et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 1999;103(2):159–165. - PMC - PubMed
    1. Eberhard A, et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000;60(5):1388–1393. - PubMed
    1. Helmlinger G, et al. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 1997;3(2):177–182. - PubMed

Publication types

MeSH terms

LinkOut - more resources